Assessing cardiovascular disease risks in the Ballana population

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the incidence, prevalence, and progression of cardiovascular disease (CVD) in a defined population in Egypt, focusing on genetic predispositions and related risk factors. A random sample of 1,200 households from the Ballana area will be selected, and participants will undergo cardiovascular profiling and continuous follow-up for up to 30 years. The study seeks to gather reliable data that will inform future cardiovascular research and guide health policy in the region.

Why it matters

Who can join: the full rules

Inclusion criteria:

* Residents of Ballana from the 1,200 randomly selected households
* Participants must have a valid National ID card
* Written informed consent

Exclusion criteria:

• Residents who are younger than 18 years

Where it's running

• Aswan Heart Centre - Magdi Yacoub Heart Foundation
  Aswān, Egypt Recruiting

Study contacts

• Principal investigator: Magdi H Yacoub, FRS OM — Imperial College London, and Magdi Yacoub Heart Foundation
• Study coordinator: Yasmine Aguib, PhD
• Email: yasmine.aguib@aswanheartcentre.com
• Phone: +201092036368

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sirolimus for ApoE4 Carriers: Testing Brain Blood Flow in Women 45-65

  Researchers will test whether sirolimus can improve brain blood flow in healthy ApoE4-positive women ages 45 to 65 compared with a placebo.

  Recruiting Phase 1 University of Missouri-Columbia · Columbia, Missouri · NCT07728175

• Germline testing for inherited risk of myeloid blood cancers

  This research will test whether a germline genetic test (MyeloGen Gene Panel) can find inherited changes linked to myeloid blood cancers in adults who have been diagnosed.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07112287

• Examining the role of vaginal microbiome in ovarian cancer detection

  This study is trying to see if the bacteria in the vagina can help detect ovarian cancer earlier by comparing samples from healthy women and those at higher risk or already diagnosed.

  Recruiting Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania · NCT06962059

• A network for advancing genomics research and improving health

  This study is testing how sharing genetic information from patients can help doctors better understand diseases and improve treatments for everyone involved.

  Recruiting at 14 sites Helix, Inc · Fort Wayne, Indiana and 13 other locations · NCT06057181

• Using genetic profiling to improve cancer treatment

  This study is testing if using genetic information can help doctors choose better treatments for cancer patients based on their specific tumor characteristics.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome · NCT06020625

• Molecular profiling and drug testing for pediatric acute myeloid leukemia

  This study is trying to learn more about pediatric acute myeloid leukemia by looking at patients' cells to find out why some treatments don’t work and to test new drug options for kids and young adults with this cancer.

  Recruiting at 28 sites Assistance Publique - Hôpitaux de Paris · Amiens and 27 other locations · NCT05772559

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.